Embracing Future Holdings Overview
- Year Founded
-
2009

- Status
-
Public
- Employees
-
7

- Stock Symbol
-
8YY

- Investments
-
1
- Share Price
-
$0.02
- (As of Thursday Closing)
Embracing Future Holdings General Information
Description
Embracing Future Holdings Ltd formerly, Biolidics Ltd is engaged in technology development, technology transfer, marketing, sales, and distribution of biomedical technology, life, and medicine science-related products and services, and investment holding. The company's business segments are: Cancer, Infectious Diseases, E-sports, and Corporate. The company generates the majority of its revenue from the E-sports segment, which involves identifying and assessing potential collaboration partners, technology, digital platforms, products, and services related to E-Sports.. Its operations are spread across Singapore, Japan, China, Europe, the United States, Hong Kong, the Philippines, Indonesia, and other countries.
Contact Information
Website
www.ebfholdings.comCorporate Office
- 37 Jalan Pemimpin
- Number 02-07
- Mapex, 577177
- Singapore
Corporate Office
- 37 Jalan Pemimpin
- Number 02-07
- Mapex, 577177
- Singapore
Embracing Future Holdings Stock Performance
As of 17-Jul-2025, Embracing Future Holdings’s stock price is $0.02. Its current market cap is $30.3M with 1.69B shares.
(As of Thursday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$0.02 | $0.02 | $30.3M | 1.69B | 1.32M |
Embracing Future Holdings Financials Summary
As of 31-Dec-2024, Embracing Future Holdings has a trailing 12-month revenue of $587K.
In Thousands, USD |
TTM 31-Dec-2024 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 |
---|---|---|---|---|
EV | 37,834 | 37,834 | 7,039 | 10,741 |
Revenue | 587 | 587 | 206 | 1,805 |
EBITDA | (2,266) | (2,266) | (900) | (6,163) |
Net Income | (2,570) | (2,570) | (1,852) | (6,798) |
Total Assets | 3,434 | 3,434 | 516 | 4,540 |
Total Debt | 1,287 | 1,287 | 1,532 | 2,247 |
Embracing Future Holdings Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Embracing Future Holdings Comparisons
Industry
Financing
Details
Embracing Future Holdings Competitors (10)
One of Embracing Future Holdings’s 10 competitors is Standard BioTools, a Formerly VC-backed company based in San Francisco, CA.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Standard BioTools | Formerly VC-backed | San Francisco, CA | ||||
Biocon | Formerly PE-Backed | Bengaluru, India | ||||
Intas Pharmaceuticals | Private Equity-Backed | Ahmedabad, India | ||||
Merck & Co. | Corporation | Rahway, NJ | ||||
Glenmark Pharmaceuticals | Corporation | Mumbai, India |
Embracing Future Holdings Patents
Embracing Future Holdings Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
JP-2019515678-A | System and method for enriching target cells in a sample | Active | 04-May-2016 | ||
AU-2016405636-A1 | Systems and methods for enriching target cells in a sample | Active | 04-May-2016 | ||
AU-2016405636-B2 | Systems and methods for enriching target cells in a sample | Active | 04-May-2016 | ||
EP-3455337-A1 | Systems and methods for enriching target cells in a sample | Inactive | 04-May-2016 | ||
EP-3455337-A4 | Systems and methods for enriching target cells in a sample | Inactive | 04-May-2016 | B01L3/502761 |
Embracing Future Holdings Signals
Embracing Future Holdings Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
Embracing Future Holdings Acquisitions (1)
Embracing Future Holdings’s most recent deal was a Merger/Acquisition with Biomedics Laboratory for . The deal was made on 26-May-2020.
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
Biomedics Laboratory | 26-May-2020 | Merger/Acquisition | Laboratory Services (Healthcare) |
Embracing Future Holdings ESG
Risk Overview
Risk Rating
Updated August, 24, 2023
30.86 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 15,109
Rank
Percentile

Healthcare
Industry
of 587
Rank
Percentile

Medical Devices
Subindustry
of 198
Rank
Percentile

Embracing Future Holdings FAQs
-
When was Embracing Future Holdings founded?
Embracing Future Holdings was founded in 2009.
-
Where is Embracing Future Holdings headquartered?
Embracing Future Holdings is headquartered in Mapex, Singapore.
-
What is the size of Embracing Future Holdings?
Embracing Future Holdings has 7 total employees.
-
What industry is Embracing Future Holdings in?
Embracing Future Holdings’s primary industry is Biotechnology.
-
Is Embracing Future Holdings a private or public company?
Embracing Future Holdings is a Public company.
-
What is Embracing Future Holdings’s stock symbol?
The ticker symbol for Embracing Future Holdings is 8YY.
-
What is the current stock price of Embracing Future Holdings?
As of 17-Jul-2025 the stock price of Embracing Future Holdings is $0.02.
-
What is the current market cap of Embracing Future Holdings?
The current market capitalization of Embracing Future Holdings is $30.3M.
-
What is Embracing Future Holdings’s current revenue?
The trailing twelve month revenue for Embracing Future Holdings is $587K.
-
Who are Embracing Future Holdings’s competitors?
Standard BioTools, Biocon, Intas Pharmaceuticals, Merck & Co., and Glenmark Pharmaceuticals are some of the 10 competitors of Embracing Future Holdings.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »